Ashok Kumar Dasmahapatra

Ashok Kumar Dasmahapatra

Auto-generated profile, based on publicly available information

Ashok Kumar Dasmahapatra

Department of Chemical Engineering, Indian Institute of Technology Guwahati, Guwahati, India

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Polymer
Verified
Journal Article
Closed access
Shatrudhan PalsaniyaShatrudhan Palsaniya
Shatrudhan Palsaniya
HNHarshal B. Nemade
Harshal B. Nemade
ADAshok Kumar Dasmahapatra
Ashok Kumar Dasmahapatra

1 July 2021 in Journal of Physics and Chemistry of Solids
Verified
Journal Article
Closed access
Shatrudhan PalsaniyaShatrudhan Palsaniya
Shatrudhan Palsaniya
HNHarshal B. Nemade
Harshal B. Nemade
ADAshok Kumar Dasmahapatra
Ashok Kumar Dasmahapatra

1 September 2019 in Carbon
Verified
Journal Article
Closed access
Shatrudhan PalsaniyaShatrudhan Palsaniya
Shatrudhan Palsaniya
HNHarshal B. Nemade
Harshal B. Nemade
ADAshok Kumar Dasmahapatra
Ashok Kumar Dasmahapatra


6 August 2020 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
SGShivani Gupta
Shivani Gupta
ADAshok Kumar Dasmahapatra
Ashok Kumar Dasmahapatra
The clinical signature of Alzheimer's disease (AD) is the deposition of aggregated Aβ fibrils that are neurotoxic to the brain. It is the major form of dementia affecting older people worldwide, impeding their normal function. Finding and testing various natural compounds to target and disrupt stable Aβ fibrils seems to be a promising and attractive therapeutic approach. Four phenolic compounds from plant sources were taken into consideration for the present work, and were initially screened by docking. Ellagic acid (REF) came out to be the best binder of the Aβ oligomer from docking studies. To test the destabilization effect of REF on the Aβ oligomer, MD simulation was conducted. The simulation outcome obtained clearly indicates a drift of terminal chains from the Aβ oligomer, leading to the disorganization of the characteristically organized cross β structure of the Aβ fibrils. Increased values of RMSD, Rg, RMSF, and SASA are indicative of the destabilization of the Aβ fibril in the presence of REF. The disruption of salt bridges and a notable decline in the number of hydrogen bonds and β-sheet content explain the conformational changes in the Aβ fibril structure, ceasing their neurotoxicity. The MM-PBSA results revealed the binding of REF to chain A of the Aβ oligomer. The destabilization potential of ellagic acid, as explained by the MD simulation study, establishes it as a promising drug for curing AD. The molecular-level details about the destabilization mechanism of ellagic acid encourage the intensive mining of other natural compounds for therapeutic intervention for AD.

1 August 2015 in Carbon
Verified
Journal Article
Closed access
SKSUNNY KUMAR
SUNNY KUMAR
Amit Kumar SinghAmit Kumar Singh
Amit Kumar Singh
ADAshok Kumar Dasmahapatra
Ashok Kumar Dasmahapatra
TMTapas Kumar Mandal
Tapas Kumar Mandal
DBDipankar Bandyopadhyay
Dipankar Bandyopadhyay